Heartseed Inc.

Heartseed Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Heartseed Inc., a pioneering clinical-stage biotech company based in Tokyo, is at the forefront of developing groundbreaking treatments for severe heart conditions. Our cutting-edge approach involves utilizing stem cells to craft cardiomyocyte spheroids—tiny heart cell clusters. These clusters are surgically transplanted into the heart to enhance its functionality.

Company Details

Employees
17
Founded
-
Address
1-2-3 Shibaura, Minato-Ku,tokyo 105-0023,japan
Email
CO****@****SEED.JP
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Minato-ku, Tokyo
Looking for a particular Heartseed Inc. employee's phone or email?

Heartseed Inc. Questions

News

Novo Withdraws from $598M Heartseed Partnership; Pursues Short-Term Profit Over iPSC Potential - BioInformant

Novo Withdraws from $598M Heartseed Partnership; Pursues Short-Term Profit Over iPSC Potential BioInformant

Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring - Fierce Biotech

Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring Fierce Biotech

Novo retreats from heart failure cell therapy collaboration with Heartseed - FirstWord Pharma

Novo retreats from heart failure cell therapy collaboration with Heartseed FirstWord Pharma

Novo Nordisk turns back on Heartseed partnership - The Pharma Letter

Novo Nordisk turns back on Heartseed partnership The Pharma Letter

Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO - BioSpace

Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO BioSpace

Heartseed Inc. Ends Partnership with Novo Nordisk, Shifts Focus to Japan - TipRanks

Heartseed Inc. Ends Partnership with Novo Nordisk, Shifts Focus to Japan TipRanks

Novo ends Heartseed deal for iPS cell-derived cardiomyocytes - BioWorld MedTech

Novo ends Heartseed deal for iPS cell-derived cardiomyocytes BioWorld MedTech

Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure - Business Wire

Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure Business Wire

Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study - Labiotech.eu

Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study Labiotech.eu

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences - PR Newswire

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences PR Newswire

Cell therapy for cardiac conditions: an interview with Takehiko Kaneko - RegMedNet

Cell therapy for cardiac conditions: an interview with Takehiko Kaneko RegMedNet

Novo Nordisk partners with Heartseed on heart failure cell therapy - PMLiVE

Novo Nordisk partners with Heartseed on heart failure cell therapy PMLiVE

Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine - Business Wire

Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine Business Wire

Heartseed Regains Rights After Novo Nordisk Partnership Ends - TipRanks

Heartseed Regains Rights After Novo Nordisk Partnership Ends TipRanks

Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy - BioSpace

Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy BioSpace

Mutsuki Takano Was Appointed as CFO at Heartseed - Business Wire

Mutsuki Takano Was Appointed as CFO at Heartseed Business Wire

Heartseed, Inc. Ends Partnership with Novo Nordisk, Maintains Development Plans - TipRanks

Heartseed, Inc. Ends Partnership with Novo Nordisk, Maintains Development Plans TipRanks

Heartseed Inc. Advances Cardiac Therapy with New Clinical Trial Submission - TipRanks

Heartseed Inc. Advances Cardiac Therapy with New Clinical Trial Submission TipRanks

Heartseed Inc. Addresses Partnership Termination and Future Strategies - TipRanks

Heartseed Inc. Addresses Partnership Termination and Future Strategies TipRanks

This company is mending broken hearts - CNN

This company is mending broken hearts CNN

Heartseed collects new venture round after $598M heart failure stem cell deal with Novo Nordisk - Fierce Biotech

Heartseed collects new venture round after $598M heart failure stem cell deal with Novo Nordisk Fierce Biotech

Heartseed - The Pharma Letter

Heartseed The Pharma Letter

Tokyo's Heartseed reaps $26M to test its stem cell injections for heart failure - Fierce Biotech

Tokyo's Heartseed reaps $26M to test its stem cell injections for heart failure Fierce Biotech

Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy - pharmaphorum

Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy pharmaphorum

Stem cell-based therapy for heart failure licensed in global collaboration - Longevity.Technology

Stem cell-based therapy for heart failure licensed in global collaboration Longevity.Technology

Novo Nordisk streamlines pipeline, ends Japanese partnership - medwatch.com

Novo Nordisk streamlines pipeline, ends Japanese partnership medwatch.com

Japan’s ten hottest biotech companies in healthcare - Labiotech.eu

Japan’s ten hottest biotech companies in healthcare Labiotech.eu

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure - BioSpace

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure BioSpace

World's first iPS cell regenerative treatment for heart failure tested in Japan - 日本テレビ

World's first iPS cell regenerative treatment for heart failure tested in Japan 日本テレビ

Heartseed Gardens: Carving a New Path - Wrightsville Beach Magazine

Heartseed Gardens: Carving a New Path Wrightsville Beach Magazine

New partnership may pave the way for first Novo Nordisk stem cell treatment - medwatch.com

New partnership may pave the way for first Novo Nordisk stem cell treatment medwatch.com

Advancing Japan’s Biotech Ecosystem: Current Initiatives and Future Outlook - BioSpectrum Asia

Advancing Japan’s Biotech Ecosystem: Current Initiatives and Future Outlook BioSpectrum Asia

Top Heartseed Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant